Resources & disclaimer

1) Domchek SM, Friebel TM, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010; 304 (9): 967-975. (PubMed Abstract)
2) King MC, Wieand S, Hale K, et al. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (nsabp-p1) Breast Cancer Prevention Trial. JAMA 2001; 286 (18):2251-2256 (PubMed Abstract)
3)McLaughlin JR, Risch HA, Lubinski J, et al. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: A case-control study. Lancet Oncology 2007; 8 (1): 26-34. (PubMed Abstract)
4) BRCA2 Gene Now Connected to Lung Cancer, Doubling a Smoker's Risk. June 02, 2014, Lebanon, NH. Genetic Causes of lung cancer explored in global genome project. http://cancer.dartmouth.edu/about_us/newsdetail/70931/ (Accessed Oct 2015)

Other Resources
National Cancer Institute: http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA
BRCA1 and BRCA2: Cancer Risk and Genetic Testing Fact Sheet - National Cancer Institute. http://www.cancer.gov/cancertopics/factsheet/risk/BRCA.
Permission to use the BRCA statistics table for this webpage, and associated book, was given by The Royal Marsden Hospital in June 2015.

***DISCLAIMER***

The information contained on my website is for general information purposes only. In no event shall I be liable for any actions that are taken as a result of the information provided on this webpage. You should not rely on this information as a substitute for, nor does it replace, professional medical advice, diagnosis or treatment.